S-Condom Uterine Tamponade in Controlling Atraumatic Postpartum Haemorrhage (PPH) - RCT
NCT ID: NCT05559840
Last Updated: 2022-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2017-01-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
NCT01842100
Tampostat for Management of Postpartum Hemorrhage
NCT02416089
Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage
NCT03870256
Misoprostol for the Treatment of Postpartum Hemorrhage
NCT00116350
A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
NCT05079061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
The control group (Group I) will be treated with condom catheter tamponade by inflating the condom with saline according to national protocol.
S-Condom Uterine Tamponade
The condom catheter will be inflated with air
Group II
The study group (Group II) will receive condom catheter that will be inflated with air
Traditional condom catheter
The condom catheter will be inflated with saline following national protocol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
S-Condom Uterine Tamponade
The condom catheter will be inflated with air
Traditional condom catheter
The condom catheter will be inflated with saline following national protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
Mamms Institute of Fistula and Womens Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Sayeba Akhter
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sayeba Akhter, Dr.
Role: PRINCIPAL_INVESTIGATOR
Mamms Institute of Fistula and Womens Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMC/PG/2017/39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.